Biocept Inc expected to post earnings of 7 cents a share - Earnings Preview

Biocept

08/11/2021 11:15

* Biocept Inc  BIOC.OQ   BIOC.O  is expected to show a rise in
quarterly revenue when it reports  results on November 10
(estimated). 
* The San Diego, California-based company is expected to report 
a 144.0% increase in revenue to $16.071 million from $6.59
million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Biocept Inc is for
earnings of 7 cents per share. For the same quarter last year,
the company reported a loss of 43 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Biocept Inc is
$13​, about 70.2% above​ its last closing price of $3.88. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.16       -0.16      -0.14     Beat    12.5
  2021                                0.19              
 Dec. 31 2020              -0.27      0.14      Beat    151.9​
 Sep. 30 2020  -0.47       -0.47      -0.43     Beat    8.5
 ​​Jun.        -0.50       -0.50      -0.50     Met     0
 30 2020                                                
                                      -1.10             ​
 Dec. 31 2019  -1.00       -1.00      -2.00     Missed  -100
 Sep. 30 2019  -2.70       -2.70      -2.50     Beat    7.4
 This summary was machine generated November 8 at 11:15 GMT.  All
figures in US dollars unless otherwise stated